Latest Wearables News

Page 1 of 13
Li-S Energy says its lithium-sulfur technology moved closer to commercialisation in 2026, with new Power Cells, defence testing and a nearly two-hour drone flight. The company is now planning the next manufacturing step while holding $15.0 million in cash.
Victor Sage
Victor Sage
10 Nov 2026
dorsaVi has commercially launched its first wearable capable of analysing movement and delivering feedback directly on-device, while its RRAM chip program moves into fabrication and testing. The progress comes alongside a post-quarter A$3.0 million capital raising, against quarter-end cash of $1.12 million and operating cash outflow of about $996,000.
Sophie Babbage
Sophie Babbage
23 Oct 2026
dorsaVi has secured A$3.0 million to expand its movement-data business for humanoid robotics while advancing its neuromorphic and RRAM chip programs. The raise comes as its first RRAM-CMOS validation chip moves into proprietary memory integration at TSMC.
Sophie Babbage
Sophie Babbage
6 Oct 2026
Epiminder has enrolled the 75th patient in its DETECT study, meeting its September target as the US site network expands to 21 centres. The company expects to reach 100 enrolments in November and remains focused on completing the 210-patient study by the end of the first half of calendar 2027.
Ada Torres
Ada Torres
17 Sept 2026
Simble Solutions’ NanoSensor has detected UV-A, UV-B, UV-C and visible wavelengths in initial laboratory testing, moving the platform into formal benchmarking. The result is an encouraging technical step, but commercial progress still depends on performance data, prototypes and customer validation.
Victor Sage
Victor Sage
14 Sept 2026
Simble Solutions has demonstrated its NanoSensor platform detecting volatile organic compounds at molecular sensitivity, marking a key step towards commercial gas sensing applications integrated with its digital platforms.
Sophie Babbage
Sophie Babbage
1 Sept 2026
Nanoveu's EMASS division has been granted a US patent for a silicon accelerator that dramatically speeds up AI object detection, underpinning its next-gen ECS-DoT chip now in production at TSMC.
Sophie Babbage
Sophie Babbage
1 Sept 2026
Bio-Gene Technology narrowed its loss to $2.33 million in FY26 while progressing key toxicity studies for Flavocide and securing a commercial foothold for Qcide in Japan. The company bolstered its balance sheet with a $3.275 million capital raise to fund ongoing development and production scale-up.
Ada Torres
Ada Torres
28 Aug 2026
Spacetalk Ltd reported a 17% revenue decline in FY26 amid a strategic reset, but mobile revenue grew 16% as the company pivots to a software-led family safety platform supported by new telco partnerships.
Sophie Babbage
Sophie Babbage
28 Aug 2026
Control Bionics has secured MHRA registration for its NeuroStrip device, unlocking commercial supply in Great Britain and launching early trials with leading UK institutions.
Ada Torres
Ada Torres
25 Aug 2026
Acusensus posted a 45% jump in FY26 revenue to $86.2 million, driven by major contract wins in New Zealand and the US, alongside robust domestic expansions. Despite a widened net loss due to a $16 million litigation settlement, adjusted EBITDA climbed 49%, reflecting operational momentum and strategic investments.
Sophie Babbage
Sophie Babbage
25 Aug 2026
Nanoveu’s half-year report reveals a sharp drop in revenue and a widening net loss, offset by key technological milestones including a 16nm AI chip tape-out, drone efficiency gains, and a strategic robotics acquisition.
Sophie Babbage
Sophie Babbage
24 Aug 2026

Browse the archive

Full archive